Community-wide implementation of targeted testing for and treatment of latent tuberculosis infection

Clinical Infectious Diseases

Volumn 29, Issue 4, 1999, Pages 880-887

  Nolan, Charles M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; TUBERCULIN;

ANTIBIOTIC THERAPY; BACTERIUM DETECTION; HEALTH PROGRAM; HUMAN; MANAGED CARE; MASS SCREENING; PATIENT COMPLIANCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES;

EID: 0033503028     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520453     Document Type: Review

References (46)

1. Leff DR, Leff AR. Tuberculosís control polícies in major metropolitan health departments in the Untied States. VI. Standard of practice in 1996. Am J Respir Crit Care Med 1997;156:1487-94.
2. Centers for Disease Control and Prevention. Tuberculosis morbidity- United States, 1997. MMWR 1998;47:253-7.
3. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco. N Engl J Med 1994;330:1703-9.
4. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City. N Engl J Med 1994;330:1710-6.
5. Zuber PLF, McKenna MT, Binkin NJ, Onorato IM, Castro KG. Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA 1997;278:304-7.
6. Whalen CC, Johnson JL, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997;337:801-8.
7. Halsey NA, Coberly JS, Desormeaux J, et al. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet 1998;351(9105):786-92.
8. Gordin F, Chaisson R, Matts J, et al. A randomized trial of 2 months of rifampin and pyrazinamide versus 12 months of isoniazid for the prevention of tuberculosis in HIV-positive, PPD-positive patients [abstract no 769]. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections. Alexandria, Virginia: Foundation for Retroviruses and Human Health, 1998.
9. Goldberg BW. Managed care and public health departments: who is responsible for the health of the population? Annu Rev Public Health 1998;19:527-37.
10. Halverson PK, Mays GP, Miller CA, Kaluzny AD, Richards TB. Managed care and the public health challenge of tuberculosis. Public Health Reports 1997;112:22-8.
11. Centers for Disease Control and Prevention. Sceening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1995; 44(RR-11):19-34.
12. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968-75.
13. Bass JB Jr, Farer LS, Hopewell PC, et al. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am J Respir Crit Care Med 1994;149:1359-74.
14. Menzies D, Chen CH, Vissndjee B. Impact of immigration on tuberculosis infection among Canadian-born schoolchildren and young adults in Montreal. Am J Respir Crit Care Med 1997;156:1915-21.
15. Centers for Disease Control. A strategic plan for the elimination of tuberculosis in the United Sales. MMWR 1989;(suppl S-3):1-25.
16. Starke JR. Tuberculosis skin testing: new schools of thought. Pediatrics 1996;98:123-5.
17. American Academy of Pediatrics. Tuberculosis. In: Peter G, ed. 1994 Red book: report of the Committee on Infectious Diseases. 23rd ed. Elk Grove Village, Illinois: American Academy of Pediatrics, 1994:480-500.
18. Cheng TL, Miller FB, Ottolini M, Brasseux C, Rosenquist G. Tuberculosis testing. Physician attitudes and practice. Arch Pediatr Adolesc Med 1996;150:682-5.
19. Serwint JR, Hall BS, Baldwin RM, Virden JM. Outcomes of annual tuberculosis screening by Mantoux test in children considered to be at high risk: results from one urban clinic. Pediatrics 1997;99:529-33.
20. Christy C, Pulcino ML, Lanphear BP, McConnochie KM. Screening for tuberculosis infection in urban children. Arch Pediatr Adolesc Med 1996;150:722-6.
21. Centers for Disease Contol and Prevention. Recommendations for prevention and control of tuberculosis among foreign-born persons: report of the working group on tuberculosis among foreign-born persons. MMWR 1998;47(RR-16):1-29.
22. Nelson KR, Bui JJ, Samel JH. Screening in special populations: a "case study" of recent Vietnamese immigrants. Am J Med 1997;102:435-40.
23. Binkin NJ, Zuber PLF, Wells CD, Tipple MA, Castro KG. Overseas screening for tuberculosis in immigrants and refugees to the United Sates: current status. Clin Infect Dis 1996;23:126-32.
24. Wells CD, Zuber PLF, Nolan CM, Binkin NJ, Goldberg SV. Tuberculosis prevention among foreign-born persons in Seattle-King County, Washington. Am J Respir Crit Care Med 1997;156:573-7.
25. Zuber PLF, Binkin NJ, Ignacio AC, et al. Tuberculosis screening for immigrants and refugees. Am J Respir Crit Care Med 1996;154:151-5.
26. DeRiemer K, Chin DP, Schecter GF, Reingold AL. Tuberculosis among immigrants and refugees. Arch Intern Med 1998;158:753-60.
27. Carlos EK, Cantwell MF, Bhatia G, Gedin S, Lewis J, Mohle-Boetani JC. Public health interventions to encourage TB class A/B1/B2 immigrants to present for TB screening. Am J Respir Crit Care Med 1998;58:1037-41.
28. Menzies D. Tuberculin skin testing & screening for TB infection in the foreign born. In: Program and abstracts of the International Union Against Tuberculosis and Lung Disease North American Region First Mid-Year Conference. Chicago: American Lung Association of Metropolitan Chicago, 1996:119-43.
29. Perlman DC, Perkins MP, Solomon N, Kochems L, Des Jarlais DC, Paone D. Tuberculosis screening at a syringe exchange program. Am J Public Health 1997;87:862-3.
30. Bock NN, Metzger BS, Tapia JR, Blumberg HM. A tuberculin screening and isoniazid preventive therapy program in an inner-city population. Am J Respir Crit Care Med 1999;159:295-300.
31. Tulsky JP, White MC, Dawson C, Hoynes TM, Goldenson J, Schecter G. Screening for tuberculosis in jail and clinic follow-up after release. Am J Public Health 1998;88:223-6.
32. White MC, Tulsky JP, Reilly P, McIntosh HW, Hoynes TM, Goldenson J. A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail. Int J Tuberc Lung Dis 1998;2:506-12.
33. Nolan CM, Roll L, Goldberg SV, Elarth A. Directly observed isoniazid preventive therapy for released jail inmates. Am J Respir Crit Care Med 1997;155:583-6.
34. Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter GF, Moss AR. Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. Arch Intern Med 1996;156:161-5.
35. Kohn MR, Arden MR, Vasilakis J, Shenker IR. Directly observed preventive therapy: turning the tide against tuberculosis. Arch Pediatr Adolesc Med 1996;150:727-9.
36. Heal G, Elwood RK, FitzGerald JM. Acceptance and safety of directly observed versus self-administered isoniazid preventive therapy in aboriginal peoples in British Columbia. Int J Tuberc Lung Dis 1998;2:979-83.
37. Graham NM, Galai N, Nelson KE, et al. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch Intern Med 1996; 156:889-94.
38. Gourevitch MN, Alcabes P, Wasserman WC, Arno PS. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis. Int J Tuberc Lung Dis 1998;2: 531-40.
39. Polesky A, Farbe HW, Gottlieb DJ, et al. Rifampin preventive therapy for tuberculosis in Boston's homeless. Am J Respir Crit Care Med 1996; 154:1473-7.
40. Villarino ME, Ridzon R, Weismuller PC, et al. Rifampin preventive therapy for tuberculosis infection: experience with 157 adolescents. Am J Respir Crit Care Med 1997;155:1735-8.
41. Sterling TR, Brehm WT, Frieden TR. Isoniazid preventive therapy in areas of high isoniazid resistance. Arch Intern Med 1995;155:1622-8.
42. Rutherford GW. Public health, communicable diseases, and managed care: will managed care improve or weaken communicable disease control? Am J Prev Med 1998;14(3S):53-9.
43. Friedman E. Prevention, public health, and managed care: obstacles and opportunities. Ant J Prev Med 1998;14(3S):102-5.
44. U.S. Preventive Services Task Force. Clinician's handbook of preventive services. Put prevention into practice. Washington, DC: U.S. Government Printing Office, 1994.
45. Taras H, Nader P, Swiger H, Fontanesi J. The School Health Innovative Programs: integrating school health and managed care in San Diego. J School Health 1998;68:22-5.
46. Miller B, Rosenbaum S, Stange PV, Solomon SL, Castro KG. Tuberculosis control in a changing health care system: model contract specifications for managed care organizations. Clin Infect Dis 1998;27: 677-86.